Onderneming Arrowhead Pharmaceuticals, Inc.
Aandelen
ARWR
US04280A1007
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
28,9 USD | +0,70% | +1,31% | -6,54% |
Vakgebied
Aantal werknemers: 525
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Drugs
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 243 | 100,0 % | 241 | 100,0 % | -1,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-12-07 | |
Director of Finance/CFO | 57 | 01-01-09 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Patrick O'brien
CMP | Compliance Officer | 60 | 01-12-14 |
Bruce Given
COO | Chief Operating Officer | 69 | 26-10-11 |
Vincent Anzalone
IRC | Investor Relations Contact | - | - |
Aaron Tan
AUD | Comptroller/Controller/Auditor | - | 01-07-21 |
Nadia Meshkova
TRE | Treasurer | - | - |
Tracie Oliver
PRN | Corporate Officer/Principal | 62 | 01-06-22 |
Matt Pulisic
PRN | Corporate Officer/Principal | - | 01-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 23-11-10 |
Michael Perry
BRD | Director/Board Member | 64 | 19-12-11 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 01-09-20 |
Chief Executive Officer | 54 | 01-12-07 | |
William Waddill
BRD | Director/Board Member | 66 | 01-01-18 |
Mauro Ferrari
BRD | Director/Board Member | 64 | 19-08-10 |
Director/Board Member | 60 | 02-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 123 896 914 | 118 327 484 ( 95,50 %) | 0 | 95,50 % |
Bedrijfsgegevens
Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard Suite 700
91105, Pasadena
+626 304 3400
http://www.arrowheadpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,54% | 3,56 mld. | |
+3,22% | 108 mld. | |
+9,30% | 104 mld. | |
+6,23% | 23,66 mld. | |
-11,68% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,47% | 16,19 mld. | |
+4,72% | 13,72 mld. | |
+35,05% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Arrowhead Pharmaceuticals, Inc. - Nasdaq
- Onderneming Arrowhead Pharmaceuticals, Inc.